Drug Type Synthetic peptide |
Synonyms APG 101.10, APG2305 |
Target |
Mechanism IL-23R inhibitors(Interleukin 23 Receptor inhibitors), TNFR2 antagonists(Tumor necrosis factor receptor superfamily member 1B antagonists), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis, Psoriatic | Preclinical | - | - |